Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline

FEMS Microbiology Letters

Volumn 294, Issue 1, 2009, Pages 24-31

  Seleem, Mohamed N ^a,b   Jain, Neeta ^a   Pothayee, Nikorn ^b   Ranjan, Ashish ^a   Riffle, J S ^b   Sriranganathan, Nammalwar ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Brucella; Doxycycline; Drug delivery; Nanoparticles; Polymers; Streptomycin

Indexed keywords

COPOLYMER; DOXYCYCLINE; NANOMATERIAL; NANOPARTICLE; POLY(ETHYLENE OXIDE B SODIUM ACRYLATE); POLY(SODIUM ACRYLATE); STREPTOMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BRUCELLA MELITENSIS; BRUCELLOSIS; CLINICAL RESEARCH; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRICITY; FEMALE; IMMUNOCOMPETENT CELL; LIVER; MACROMOLECULE; MOUSE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTI-BACTERIAL AGENTS; BRUCELLA MELITENSIS; BRUCELLOSIS; COLONY COUNT, MICROBIAL; DOXYCYCLINE; DRUG CARRIERS; FEMALE; HUMANS; LIVER; MICE; MICE, INBRED BALB C; NANOPARTICLES; SPLEEN; STREPTOMYCIN;

BRUCELLA; BRUCELLA MELITENSIS; MUS;

EID: 63849319243     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2009.01530.x     Document Type: Article

References (34)

1. Alp E, Koc RK, Durak AC, Yildiz O, Aygen B, Sumerkan B Doganay M (2006) Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647]. BMC Infect Dis 6 : 72.
2. Aman T, AR, Kulsoom R Khokhar I (1995) Spectrophotometric determination of some antipsychotic phenothiazines Anal. Letter 28 : 881 892.
3. Ariza J, Gudiol F, Pallares R, Viladrich PF, Rufi G, Corredoira J Miravitlles MR (1992) Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ann Intern Med 117 : 25 30.
4. Belal F, El-Ashry SM, El Kerdawy MM El Wasseef DR (2001) Spectrofluorimetric determination of streptomycin in dosage forms and in spiked plasma using 9,10-phenanthraquinone. J Pharmaceut Biomed 26 : 435 441.
5. Corbel MJ (1997) Brucellosis: an overview. Emerg Infect Dis 3 : 213 221.
6. de la Torre PM, Torrado G Torrado S (2005) Poly (acrylic acid) chitosan interpolymer complexes for stomach controlled antibiotic delivery. J Biomed Mater Res B 72 : 191 197.
7. DelVecchio VG, Kapatral V, Redkar RJ et al 2002) The genome sequence of the facultative intracellular pathogen Brucella melitensis. P Natl Acad Sci USA 99 : 443 448.
8. Deutel B, Greindl M, Thaurer M Bernkop-Schnurch A (2008) Novel insulin thiomer nanoparticles: in vivo evaluation of an oral drug delivery system. Biomacromolecules 9 : 278 285.
9. Dizbay M, Kilic S, Hizel K Arman D (2007) Tigecycline: its potential for treatment of brucellosis. Scand J Infect Dis 39 : 432 434.
10. Ersoy Y, Sonmez E, Tevfik MR But AD (2005) Comparison of three different combination therapies in the treatment of human brucellosis. Trop Doct 35 : 210 212.
11. Falagas ME Bliziotis IA (2006) Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob Agents Ch 50 : 22 33.
12. Forge A Schacht J (2000) Aminoglycoside antibiotics. Audiol Neuro-Otol 5 : 3 22.
13. Gaspar MM, Cruz A, Fraga AG, Castro AG, Cruz ME Pedrosa J (2008) Developments on drug delivery systems for the treatment of mycobacterial infections. Curr Top Med Chem 8 : 579 591.
14. Gelperina S, Kisich K, Iseman MD Heifets L (2005) The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care 172 : 1487 1490.
15. Grillo MJ, De Miguel MJ, Munoz PM, Marin CM, Ariza J Blasco JM (2006) Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice. J Antimicrob Chemoth 58 : 622 626.
16. Jennings GJ, Hajjeh RA, Girgis FY et al 2007) Brucellosis as a cause of acute febrile illness in Egypt. T Roy Soc Trop Med H 101 : 707 713.
17. Khalil RM, Murad FE, Yehia SA, El-Ridy MS Salama HA (1996) Free versus liposome-entrapped streptomycin sulfate in treatment of infections caused by Salmonella enteritidis. Pharmazie 51 : 182 184.
18. Lecaroz C, Blanco-Prieto MJ, Burrell MA Gamazo C (2006) Intracellular killing of Brucella melitensis in human macrophages with microsphere- encapsulated gentamicin. J Antimicrob Chemoth 58 : 549 556.
19. Lecaroz MC, Blanco-Prieto MJ, Campanero MA, Salman H Gamazo C (2007) Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice. Antimicrob Agents Ch 51 : 1185 1190.
20. Pappas G, Akritidis N Tsianos E (2005) Effective treatments in the management of brucellosis. Expert Opin Pharmaco 6 : 201 209.
21. Pappas G, Papadimitriou P, Akritidis N, Christou L Tsianos EV (2006a) The new global map of human brucellosis. Lancet Infect Dis 6 : 91 99.
22. Pappas G, Panagopoulou P, Christou L Akritidis N (2006b) Brucella as a biological weapon. Cell Mol Life Sci 63 : 2229 2236.
23. Reveneau N, Crane DD, Fischer E Caldwell HD (2005) Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis. Antimicrob Agents Ch 49 : 1787 1793.
24. Segura S, Gamazo C, Irache JM Espuelas S (2007) Gamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus. Antimicrob Agents Ch 51 : 1310 1314.
25. Seleem MN, Boyle SM Sriranganathan N (2008) Brucella: a pathogen without classic virulence genes. Vet Microbiol 129 : 1 14.
26. Shah LK Amiji MM (2006) Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS. Pharm Res 23 : 2638 2645.
27. Shasha B, Lang R Rubinstein E (1994) Efficacy of combinations of doxycycline and rifampicin in the therapy of experimental mouse brucellosis. J Antimicrob Chemoth 33 : 545 551.
28. Sijian H, Chaikor EL, Taton D Gnanou Y (2003) Synthesis of water-soluble star-block and dendrimer-like copolymers based on poly(ethylene oxide) and poly(acrylic acid). Macromolecules 36 : 3874 3881.
29. Solera J, Rodriguez-Zapata M, Geijo P et al 1995) Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. Antimicrob Agents Ch 39 : 2061 2067.
30. Solera J, Martinez-Alfaro E Espinosa A (1997) Recognition and optimum treatment of brucellosis. Drugs 53 : 245 256.
31. Trubetskoy VS, Wong SC, Subbotin V, Budker VG, Loomis A, Hagstrom JE Wolff JA (2003) Recharging cationic DNA complexes with highly charged polyanions for in vitro and in vivo gene delivery. Gene Ther 10 : 261 271.
32. Vakulenko SB Mobashery S (2003) Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 16 : 430 450.
33. Verhoef HEJaJC (1998) Macromolecules as safe penetration enhancers for hydrophilic drugs - a fiction? Pharm Sci Technol To 1 : 370 376.
34. Weidner J (2001) Drug delivery. Drug Discov Today 6 : 216 217.